4 lessons learned from conducting virtual trials: A sit-down with Iqvia

By Melissa Fassbender

- Last updated on GMT

Related tags: IQVIA, Virtual clinical trials, Remote clinical trials, Decentralized trials, Contract research, Wearables, Protocol development

It’s a lot more complicated than a simple technology – says Iqvia global head of virtual trials, who shares four lessons learned during a discussion at the company’s headquarters in Research Triangle Park.

Josh Rose is the Vice President of Clinical Development Strategy and Innovation, and the Global Head Virtual Trial Operations at Iqvia.

To discuss the company’s lessons learned from conducting virtual trials, Outsourcing-Pharma went to the source and sat down with Rose at Iqvia’s headquarters in Durham, NC.

Speaking to the complexity of running a trial with this model, Rose said “being cutting edge is not enough.” ​It’s important to start early, “embed virtual thinking into your protocol,” ​he added, addressing four key areas to keep in mind.

For the full discussion, watch the video above.

Related news

Show more

Related products

show more

SmartSignals Study Oversight

SmartSignals Study Oversight

Signant Health | 24-Jan-2022 | Product Brochure

Today, sponsors and study teams often struggle to support the growing variety and volume of clinical data. The right technology thought will help your...

The APAC Advantages

The APAC Advantages

Catalent Pharma Solutions | 18-Jan-2022 | Insight Guide

Over recent years, the Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies.

CellCarta - Mapping Precision Medicine

CellCarta - Mapping Precision Medicine

CellCarta | 17-Jan-2022 | Product Presentation

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Planning Your Preclinical Assessment

Planning Your Preclinical Assessment

Altasciences | 17-Jan-2022 | Technical / White Paper

There are many challenges associated with early drug discovery and development. Advancing your best candidate for regulatory submissions requires a careful...

Related suppliers

Follow us


View more